Peripheral endomorphin-1 levels are suppressed in diabetic patients

Diabetes Research and Clinical Practice

Volumn 87, Issue 2, 2010, Pages 200-203

  Xia, Fang zhen ^a   Lu, Ying li ^a   Chen, Yi ^a   Gu, Ting ^a   Zhang, Hui xin ^a   Yu, Jiao ^a   Zhao, Li juan ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Diabetes mellitus; Endomorphin 1; Energy metabolism

Indexed keywords

ANTIHYPERTENSIVE AGENT; ENDOMORPHIN 1; GLUCOSE; ORAL ANTIDIABETIC AGENT;

AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DIET THERAPY; ENERGY METABOLISM; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; MEAL; POSTPRANDIAL STATE; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS; DIET; FEMALE; HUMANS; MALE; MIDDLE AGED; OLIGOPEPTIDES; PATIENT SELECTION; POSTPRANDIAL PERIOD; RADIOIMMUNOASSAY; REFERENCE VALUES;

EID: 74449092304     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.11.017     Document Type: Article

References (14)

1. Okada Y., Tsuda Y., Bryant S.D., and Lazarus L.H. Endomorphins and related opioid peptides. Vitam. Horm. 65 (2002) 257-279
2. Fichna J., Janecka A., Costentin J., and Do Rego J.C. The endomorphin system and its evolving neurophysiological role. Pharmacol. Rev. 59 Mar (1) (2007) 88-123
3. Kastin A.J., Fasold M.B., Smith R.R., Horner K.A., and Zadina J.E. Saturable brain-to-blood transport of endomorphins. Exp. Brain Res. 139 July (1) (2001) 70-75
4. Asakawa A., Inui A., Momose K., Ueno N., Fujino M.A., and Kasuga M. Endomorphins have orexigenic and anxiolytic activities in mice. Neuroreport 9 July (10) (1998) 2265-2267
5. Asakawa A., Inui A., Ueno N., Fujimiya M., Fujino M.A., and Kasuga M. Endomorphin-1, an endogenous mu-opioid receptor-selective agonist, stimulates oxygen consumption in mice. Horm. Metab. Res. 32 Feb (2) (2000) 51-52
6. García-Barrado M.J., Iglesias-Osma M.C., Rodríguez R., Martín M., and Moratinos J. Role of mu-opioid receptors in insulin release in the presence of inhibitory and excitatory secretagogues. Eur. J. Pharmacol. 448 July (1) (2002) 95-104
7. The expert committee on the diagnosis and classification of diabetes mellitus: report of the expert committee on the diagnosis and classification of diabetes mellitus, Diabetes Care 20 (1997) 1183-1197.
8. Seale J.V., Jessop D.S., and Harbuz M.S. Immunohistochemical staining of endomorphin 1 and 2 in the immune cells of the spleen. Peptides 25 Jan (1) (2004) 91-94
9. Goldberg I.E., Rossi G.C., Letchworth S.R., Mathis J.P., Ryan-Moro J., Leventhal L., et al. Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain. J. Pharmacol. Exp. Ther. 286 Aug (2) (1998) 1007-1013
10. Cheng J.T., Liu I.M., Chi T.C., and Tzeng T.F. Increase of opioid μ-receptor gene expression in streptozotocin-induced diabetic rats. Horm. Metab. Res. 33 Aug (8) (2001) 467-471
11. Champion H.C., Zadina J.E., Kastin A.J., Hackler L., Ge L.J., and Kadowitz P.J. Endomorphin 1 and 2, endogenous ligands for the mu-opioid receptor, decrease cardiac output, and total peripheral resistance in the rat. Peptides 18 9 (1997) 1393-1397
12. Champion H.C., Zadina J.E., Kastin A.J., and Kadowitz P.J. The endogenous mu-opioid agonists, endomorphin 1 and 2, have vasodilator activity in the hindquarters vascular bed of the rat. Life Sci. 61 26 (1997) 409-415
13. Champion H.C., Zadina J.E., Kastin A.J., Hackler L., Ge L.-J., and Kadowitz P.J. Endomorphin 1 and 2, the endogenous μ-opioid agonists, have novel hypotensive activity in the rabbit. Biochem. Biophys. Res. Commun. 235 (1997) 567-570
14. Champion H.C., Zadina J.E., Kastin A.J., and Kadowitz P.J. Endomorphin 1 and 2 have vasodepressor activity in the anesthetized mouse. Peptides 19 (1998) 925-929